CINGULATE INC.(CING),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CING CINGULATE INC.

Market Closed 09-04 16:00:00 EDT

5.10

-0.12

-2.30%

盘后5.04

-0.06-1.15%

19:30 EDT

High5.50	Low5.02	Vol106.98K
Open5.21	D1 Closing5.22	Amplitude9.16%
Mkt Cap74.16M	Tradable Cap71.97M	Total Shares14.54M
T/O546.16K	T/O Rate0.76%	Tradable Shares14.11M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CING","market":"US","secType":"STK","nameCN":"CINGULATE INC.","latestPrice":5.1,"timestamp":1788552000000,"preClose":5.22,"halted":0,"volume":106977,"hourTrading":{"tag":"盘后","latestPrice":5.0416,"preClose":5.1,"latestTime":"19:30 EDT","volume":1476,"amount":7573.8864,"timestamp":1788564604211,"change":-0.0584,"changeRate":-0.011451,"amplitude":0.021255},"delay":0,"changeRate":-0.022988505747126457,"floatShares":14111800,"shares":14541800,"eps":-3.56,"marketStatus":"Market Closed","change":-0.12,"latestTime":"09-04 16:00:00 EDT","open":5.21,"high":5.4979,"low":5.02,"amount":546161.4027792,"amplitude":0.091552,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.56,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1633579200000,"exchange":"NASDAQ","adjPreClose":5.22,"preHourTrading":{"tag":"盘前","latestPrice":5.19,"preClose":5.22,"latestTime":"09:29 EDT","volume":205,"amount":1069.76011,"timestamp":1788528599111,"change":-0.03,"changeRate":-0.005747,"amplitude":0.01341},"postHourTrading":{"tag":"盘后","latestPrice":5.0416,"preClose":5.1,"latestTime":"19:30 EDT","volume":1476,"amount":7573.8864,"timestamp":1788564604211,"change":-0.0584,"changeRate":-0.011451,"amplitude":0.021255},"volumeRatio":0.975977,"impliedVol":1.3916,"impliedVolPercentile":0.1789},"requestUrl":"/m/hq/s/CING","defaultTab":"news","newsList":[{"id":"2662089722","title":"Cingulate Price Target Cut to $9.00/Share from $10.00 by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662089722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662089722?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:16","pubTimestamp":1787591760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CING/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275889","title":"Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275889?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Hea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","XLV","LABU","CING","BK4588","BK4007","BK4137","AGL","BK4196","BK4585","BK4539","ELOX","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216246","title":"Roth MKM Remains a Buy on Cingulate Inc (CING)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661216246?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:15","pubTimestamp":1787523321,"startTime":"0","endTime":"0","summary":"In a report released today, Boobalan Pachaiyappan from Roth MKM reiterated a Buy rating on Cingulate Inc, with a price target of $9.00. According t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-cingulate-inc-cing-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/roth-mkm-remains-a-buy-on-cingulate-inc-cing-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661246215","title":"Cingulate price target lowered to $9 from $10 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2661246215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661246215?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:10","pubTimestamp":1787523012,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on Cingulate (CING) to $9 from $10 and keeps a Buy rating on the shares following the Q2 report. Cingu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-price-target-lowered-to-9-from-10-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-price-target-lowered-to-9-from-10-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660811404","title":"U.S. Research Roundup-Amgen, Analog Devices, Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2660811404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660811404?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:47","pubTimestamp":1787212055,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, ModernaAug 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Analog D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H0HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KIDS","ALL","PJP","XLV","LOW","ALIT","IHF","TJX","WISE","MRNA","IHE","ABBV","EPR","RARE","SNOW","LNSR","CRWD","PCTY","CING","HCA","LWAY","WOLF","EL","MRK","MSGE","AIPI","APA","FRNM","IBBQ","SPHR","NIQ","KBWP","ADI","UNCY","MRVL","ARTY","BILL","PGR","XNTK","TGT","WDAY","RLAY","ADSK","NRGV","SMHX","TRUH","WHD","GKOS","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660314409","title":"Cingulate Inc : Ascendiant Capital Markets Cuts Target Price to $44 from $52","url":"https://stock-news.laohu8.com/highlight/detail?id=2660314409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660314409?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:49","pubTimestamp":1787208570,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0B7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144397","title":"Maxim Group Keeps Their Buy Rating on Cingulate Inc (CING)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144397","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144397?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:55","pubTimestamp":1786712142,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman reiterated a Buy rating on Cingulate Inc today and set a price target of $8.00. According to TipRanks, Rahman is an ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-buy-rating-on-cingulate-inc-cing-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-buy-rating-on-cingulate-inc-cing-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659615272","title":"Cingulate Q2 EPS $(0.45) Beats $(0.63) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659615272","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659615272?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:57","pubTimestamp":1786625860,"startTime":"0","endTime":"0","summary":"Cingulate (NASDAQ:CING) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.63) by 28.57 percent. This is a 60.53 percent increase over losses of $(1.14) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61173147/cingulate-q2-eps-0-45-beats-0-63-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659815471","title":"Press Release: Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2659815471","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659815471?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:30","pubTimestamp":1786624200,"startTime":"0","endTime":"0","summary":"contract development and manufacturing organization, to complete the. requested CMC work and advance process validation for CTx-1301, which. -- Product Distribution: On July 21, 2026, the Company signed an exclusive. services agreement with Prasco, LLC to establish the commercial. distribution infrastructure for the launch of CTx-1301, providing. designed to support broad national availability across maj","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668461.USD","LU2746668974.SGD","CING","IE00BKVL7J92.USD","LU0267386448.USD","LU2237443978.SGD","BK4139","PRGS","BK4585","LU0149725797.USD","LU2237443622.USD","03160","BK4588","CMC","LU1363072403.SGD","LU0170899867.USD","IE00BHPRN162.USD","BK4097","LU0971096721.USD","LU2237443382.USD","LU2237443465.HKD","BK4006","BK4007","TM","IE00BFXG1179.USD","BK4604","LU2237443895.HKD","ABVC","LU0882574139.USD","LU2065732104.USD","IE00BZ1G4Q59.USD","BK4099","BK4555","IE00B1BXHZ80.USD","ADHD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913001","title":"Cingulate publishes peer-reviewed data on CTx-1301 pharmacokinetic profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913001?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:20","pubTimestamp":1786454432,"startTime":"0","endTime":"0","summary":"Cingulate (CING) announced the publication of “Comparative Bioavailability of Trimodal CTx-1301 Versus Bimodal Dexmethylphenidate” in the peer-revi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cingulate-publishes-peer-reviewed-data-on-ctx-1301-pharmacokinetic-profile-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cingulate-publishes-peer-reviewed-data-on-ctx-1301-pharmacokinetic-profile-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658352918","title":"Cingulate Publishes Peer-Reviewed Pharmacokinetic Study of ADHD Candidate CTx-1301 in CNS Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658352918","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658352918?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:31","pubTimestamp":1786451516,"startTime":"0","endTime":"0","summary":"Cingulate publishes peer-reviewed pharmacokinetic study of ADHD candidate CTx-1301 in CNS DrugsCingulate published a peer-reviewed pharmacokinetic analysis of CTx-1301 in CNS Drugs; results were prese","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL6TXFyM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BKPKM429.USD","NDAQ","SG9999014021.USD","LU0314104364.USD","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","CING","BK4007","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","SG9999014039.USD","BCDF","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658150918","title":"Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2658150918","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658150918?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:30","pubTimestamp":1786451400,"startTime":"0","endTime":"0","summary":"Findings further validate Cingulate’s Precision Timed Release (PTR) platform and its trimodal drug delivery approachKANSAS CITY, Kan., Aug.  11, 2026  (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342703/0/en/cingulate-publishes-peer-reviewed-data-demonstrating-ctx-1301-s-differentiated-pharmacokinetic-profile.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADHD","BK4007","ABVC","CING","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655287746","title":"Cingulate Phase 3 ADHD Trial Results for CTx-1301 Published in Journal of Child and Adolescent Psychopharmacology","url":"https://stock-news.laohu8.com/highlight/detail?id=2655287746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655287746?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:33","pubTimestamp":1785414790,"startTime":"0","endTime":"0","summary":"Cingulate Phase 3 ADHD trial results for CTx-1301 published in Journal of Child and Adolescent PsychopharmacologyCingulate disclosed open-access publication of Phase 3 results for ADHD candidate CTx-1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL15hJpL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","LU0314104364.USD","BCDF","CING","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4007","BK4588","SG9999014005.SGD","SG9999014021.USD","NDAQ","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","SG9999014039.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655776038","title":"Cingulate - Ctx-1301 Shows Statistically Significant Improvements over Placebo in Phase 3 Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2655776038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655776038?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:30","pubTimestamp":1785414601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nTUA4FHTTT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CINGW","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655387764","title":"Cingulate Announces Publication of Phase 3 Adhd Trial Results in Journal of Child and Adolescent Psychopharmacology","url":"https://stock-news.laohu8.com/highlight/detail?id=2655387764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655387764?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:30","pubTimestamp":1785414601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nTUA4FHTTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CINGW","CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776343","title":"Cingulate Restructures Leadership, Eliminates Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776343","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776343?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:36","pubTimestamp":1784838998,"startTime":"0","endTime":"0","summary":"Cingulate Inc ( ($CING) ) has provided an update. On July 17, 2026, Cingulate Inc.’s Board of Directors decided to eliminate the Chief Legal Office...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-restructures-leadership-eliminates-chief-legal-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-restructures-leadership-eliminates-chief-legal-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653577544","title":"Cingulate Eliminates Chief Legal Officer Role, Nilay Patel to Depart Aug. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2653577544","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653577544?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:27","pubTimestamp":1784838468,"startTime":"0","endTime":"0","summary":"Cingulate eliminates chief legal officer role, Nilay Patel to depart Aug. 3Cingulate eliminated the chief legal officer position under a board decision dated July 17, 2026.Nilay Patel will step down a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL7dDh0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453518","title":"Cingulate enhances equity plan and updates board leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453518","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651453518?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:06","pubTimestamp":1784102791,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Cingulate Inc ( ($CING) ). At Cingulate Inc.’s 2026 Annual Meeting of Stockholders held on July 9, 2026, shareh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-enhances-equity-plan-and-updates-board-leadership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-enhances-equity-plan-and-updates-board-leadership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CING","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648683351","title":"Cingulate Inc Added to Broad Russell 3000E Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2648683351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648683351?lang=en_us&edition=fundamental","pubTime":"2026-07-02 21:30","pubTimestamp":1782999032,"startTime":"0","endTime":"0","summary":"Cingulate Inc ( ($CING) ) has issued an announcement. On June 30, 2026, Cingulate’s subsidiary Cingulate Therapeutics LLC amended the employment ag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-added-to-broad-russell-3000e-index?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cingulate-inc-added-to-broad-russell-3000e-index?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CING"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648500733","title":"Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®","url":"https://stock-news.laohu8.com/highlight/detail?id=2648500733","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648500733?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:30","pubTimestamp":1782995400,"startTime":"0","endTime":"0","summary":"CEO Shane Schaffer: Inclusion Demonstrates Continued Growth and Enhanced Visibility Among Institutional InvestorsKANSAS CITY, Kan., July  02, 2026  (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/02/3321301/0/en/Cingulate-Inc-NASDAQ-CING-Added-to-Russell-3000E.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONEQ","GPIQ","MNQmain","CING","ADHD","QQQ","TECS",".IXIC","ABVC","BK4139","QLD","QID","NQmain","QQQJ","PSQ","QQQM","QQQE","IYW","JEPQ","NDX","NVIW.SI","SQQQ","QDTE","QQQA","TQQQ","BK4007","TQQY","QQQY","FTEC","QYLG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cingulate.com","stockEarnings":[{"period":"1week","weight":-0.0423},{"period":"1month","weight":0.0324},{"period":"3month","weight":0.1346},{"period":"6month","weight":-0.2068},{"period":"1year","weight":0.3456},{"period":"ytd","weight":0.1751}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.143656},{"month":2,"riseRate":0.4,"avgChangeRate":0.01358},{"month":3,"riseRate":0.4,"avgChangeRate":-0.044027},{"month":4,"riseRate":0.2,"avgChangeRate":-0.087813},{"month":5,"riseRate":0,"avgChangeRate":-0.196272},{"month":6,"riseRate":0.8,"avgChangeRate":0.034217},{"month":7,"riseRate":0.4,"avgChangeRate":-0.069094},{"month":8,"riseRate":0.8,"avgChangeRate":0.257116},{"month":9,"riseRate":0.2,"avgChangeRate":-0.127925},{"month":10,"riseRate":0.25,"avgChangeRate":-0.153936},{"month":11,"riseRate":0.25,"avgChangeRate":-0.072096},{"month":12,"riseRate":1,"avgChangeRate":0.130431}],"exchange":"NASDAQ","name":"CINGULATE INC.","nameEN":"CINGULATE INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CINGULATE INC.(CING),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CINGULATE INC.(CING) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CINGULATE INC.,CING,CINGULATE INC.股票,CINGULATE INC.股票老虎,CINGULATE INC.股票老虎国际,CINGULATE INC.行情,CINGULATE INC.股票行情,CINGULATE INC.股价,CINGULATE INC.股市,CINGULATE INC.股票价格,CINGULATE INC.股票交易,CINGULATE INC.股票购买,CINGULATE INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CINGULATE INC.(CING),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CINGULATE INC.(CING) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}